A nuclear budding mechanism in transiently arrested cells generates drug-sensitive and drug-resistant cells

Biochemical Pharmacology

Volumn 78, Issue 2, 2009, Pages 123-132

  Mansilla, Sylvia ^a   Bataller, Marc ^a   Portugal, José ^a  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Aneuploidy; HCT116 cells; Mitotic catastrophe; Neosis; p21WAF; Senescence

Indexed keywords

3',3' N XYLENYLBIS(DAUNORUBICIN); ALPHA ACTIN; CAMPTOTHECIN; CELL CYCLE PROTEIN; CISPLATIN; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; ETOPOSIDE; PACLITAXEL; PROTEIN MOS; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL NUCLEUS; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL SIZE; CLONOGENIC ASSAY; COLON CARCINOMA; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; MEIOSIS; METAPHASE; MITOSIS; MULTINUCLEAR CELL; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL AGING; CELL CYCLE; CELL NUCLEUS; CELL NUCLEUS DIVISION; CELL PROLIFERATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HCT116 CELLS; HUMANS;

EID: 67349257415     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.03.027     Document Type: Article

References (46)

1. Suijkerbuijk S.J., and Kops G.J. Preventing aneuploidy: the contribution of mitotic checkpoint proteins. Biochim Biophys Acta 1786 (2008) 24-31
2. Wang X., Cheung H.W., Chun A.C., Jin D.Y., and Wong Y.C. Mitotic checkpoint defects in human cancers and their implications to chemotherapy. Front Biosci 13 (2008) 2103-2114
3. Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19 (2000) 2165-2170
4. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 116 (2004) 221-234
5. Weaver B.A., and Cleveland D.W. Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 8 (2005) 7-12
6. Castedo M., Perfettini J.L., Roumier T., Valent A., Raslova H., Yakushijin K., et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 23 (2004) 4362-4370
7. Mansilla S., Priebe W., and Portugal J. Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms. Cell Cycle 5 (2006) 53-60
8. WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 61 (2001) 7660-7668
9. Ferbeyre G., de Stanchina E., Lin A.W., Querido E., McCurrach M.E., Hannon G.J., et al. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 22 (2002) 3497-3508
10. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res 63 (2003) 2705-2715
11. waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18 (1999) 4808-4818
12. Gewirtz D.A., Holt S.E., and Elmore L.W. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76 (2008) 947-957
13. Roninson I.B., Broude E.V., and Chang B.-D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Update 4 (2001) 303-313
14. Mansilla S., Bataller M., and Portugal J. Mitotic catastrophe as a consequence of chemotherapy. Anticancer Agents Med Chem 6 (2006) 589-602
15. Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24 (2005) 4765-4777
16. Hyzy M., Bozko P., Konopa J., and Skladanowski A. Antitumour imidazoacridone C-1311 induces cell death by mitotic catastrophe in human colon carcinoma cells. Biochem Pharmacol 69 (2005) 801-809
17. Vakifahmetoglu H., Olsson M., Tamm C., Heidari N., Orrenius S., and Zhivotovsky B. DNA damage induces two distinct modes of cell death in ovarian carcinomas. Cell Death Differ 15 (2008) 555-566
18. Lock R.B., and Stribinskiene L. Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56 (1996) 4006-4012
19. Niida H., Katsuno Y., Banerjee B., Hande M.P., and Nakanishi M. Specific role of Chk1 phosphorylations in cell survival and checkpoint activation. Mol Cell Biol 27 (2007) 2572-2581
20. Ianzini F., and Mackey M. Mitotic catastrophe. In: Gewirtz D.A., Holt S.E., and Grant S. (Eds). Apoptosis, senescence and cancer (2007), Humana Press, New Jersey 73-91
21. Bataller M., Méndez C., Salas J.A., and Portugal J. Mithramycin SK modulates polyploidy and cell death in colon carcinoma cells. Mol Cancer Ther 7 (2008) 2988-2997
22. Chang B.D., Swift M.E., Shen M., Fang J., Broude E.V., and Roninson I.B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 99 (2002) 389-394
23. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., and Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23 (2004) 2825-2837
24. Demidenko Z.N., Kalurupalle S., Hanko C., Lim C.U., Broude E., and Blagosklonny M.V. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis. Oncogene 27 (2008) 4402-4410
25. Blagosklonny M.V. Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events. Cell Cycle 6 (2007) 70-74
26. Rajaraman R., Guernsey D.L., Rajaraman M.M., and Rajaraman S.R. Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int 6 (2006) 25
27. Erenpreisa J., Ivanov A., Wheatley S.P., Kosmacek E.A., Ianzini F., Anisimov A.P., et al. Endopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinase. Cell Biol Int 32 (2008) 1044-1056
28. Ivanov A., Cragg M.S., Erenpreisa J., Emzinsh D., Lukman H., and Illidge T.M. Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. J Cell Sci 116 (2003) 4095-4106
29. Ullah Z., Kohn M.J., Yagi R., Vassilev L.T., and DePamphilis M.L. Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity. Genes Dev 22 (2008) 3024-3036
30. Sundaram M., Guernsey D.L., Rajaraman M.M., and Rajaraman R. Neosis: a novel type of cell division in cancer. Cancer Biol Ther 3 (2004) 207-218
31. Erenpreisa J., Kalejs M., Ianzini F., Kosmacek E.A., Mackey M.A., Emzinsh D., et al. Segregation of genomes in polyploid tumour cells following mitotic catastrophe. Cell Biol Int 29 (2005) 1005-1011
32. Shimizu N., Itoh N., Utiyama H., and Wahl G.M. Selective entrapment of extrachromosomally amplified DNA by nuclear budding and micronucleation during S phase. J Cell Biol 140 (1998) 1307-1320
33. Shimizu N., Misaka N., and Utani K. Nonselective DNA damage induced by a replication inhibitor results in the selective elimination of extrachromosomal double minutes from human cancer cells. Genes Chromosomes Cancer 46 (2007) 865-874
34. Villamarín S., Mansilla S., Ferrer-Miralles N., Priebe W., and Portugal J. A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631. Eur J Biochem 270 (2003) 764-770
35. Biroccio A., Amodei S., Antonelli A., Benassi B., and Zupi G. Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis. J Biol Chem 278 (2003) 35693-35701
36. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92 (1995) 9363-9367
37. Plumb J.A. Cell sensitivity assays: clonogenic assay. Methods Mol Med 88 (2004) 159-164
38. Ianzini F., Bertoldo A., Kosmacek E.A., Phillips S.L., and Mackey M.A. Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells. Cancer Cell Int 6 (2006) 11
39. Sliwinska M.A., Mosieniak G., Wolanin K., Babik A., Piwocka K., Magalska A., et al. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech Ageing Dev 130 (2009) 24-32
40. (Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18 (1998) 629-643
41. Lin Y.C., and Wang F.F. Mechanisms underlying the pro-survival pathway of p53 in suppressing mitotic death induced by adriamycin. Cell Signal 20 (2008) 258-267
42. Kalejs M., Ivanov A., Plakhins G., Cragg M.S., Emzinsh D., Illidge T.M., et al. Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe. BMC Cancer 6 (2006) 6
43. Fukasawa K., and Vande Woude G.F. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol 17 (1997) 506-518
44. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
45. Broude E.V., Demidenko Z.N., Vivo C., Swift M.E., Davis B.M., Blagosklonny M.V., et al. p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 6 (2007) 1468-1471
46. Mansilla S., and Portugal J. Sp1 transcription factor as a target for anthracyclines: effects on gene transcription. Biochimie 90 (2008) 976-987